Physician profile
Evan Walker Carr
NPI 1104502152
$1,287.39
in general payments reported to CMS, 2019-2025
10 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $109 · 2024: $717 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.40 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $257.24 | 2024-2025 | Idose, Idosetr |
| Johnson & Johnson Surgical Vision, INC. | $218.85 | 2024 | Tecnis Simplicity, Tecnis Iol |
| Abbvie INC. | $155.52 | 2024 | |
| New World Medical,INC. | $139.42 | 2025 | Kahook Dual Blade, Streamline, Via360 |
| Amgen INC. | $131.26 | 2025 | Tepezza |
| Apellis Pharmaceuticals, INC. | $108.80 | 2023 | Syfovre |
| Oyster Point Pharma, INC. | $100.00 | 2024 | Tyrvaya |
| Dompe US, INC. | $92.90 | 2024 | Oxervate |
| Genentech USA, INC. | $67.11 | 2025 | Vabysmo |
| Janssen Pharmaceuticals, INC | $16.29 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.